Low FODMAP Diet for Irritable Bowel Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a low FODMAP diet (low in certain carbohydrates that can cause digestive issues) can help people with irritable bowel syndrome, particularly those who primarily experience diarrhea. Researchers aim to understand how this diet affects the gut and improves symptoms. The trial seeks to determine if dietary changes can significantly benefit those struggling with IBS. Individuals who have experienced IBS with diarrhea for some time and have normal recent blood and stool tests might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to valuable research that could lead to improved dietary recommendations for IBS sufferers.
Will I have to stop taking my current medications?
The trial requires that you do not regularly use certain medications like mast cell stabilizers, anti-histamines, NSAIDs (except daily baby aspirin), steroids, or bile-acid binders. If you are on these, you may need to stop taking them to participate.
What prior data suggests that the FODMAP diet is safe for individuals with IBS?
Research has shown that the low FODMAP diet is generally safe for people with IBS. Studies indicate that this diet can reduce symptoms in up to 86% of individuals with IBS by limiting certain hard-to-digest carbohydrates, which helps reduce bloating and diarrhea.
Evidence suggests that following this diet long-term is safe and manageable. However, not everyone experiences the same benefits, as about 25% of individuals may not see improvement. For most, though, the low FODMAP diet is well-tolerated and can effectively manage IBS symptoms.12345Why are researchers excited about this trial?
The FODMAP diet is unique because it focuses on reducing certain types of carbohydrates that are poorly absorbed in the small intestine, which can trigger symptoms in people with Irritable Bowel Syndrome (IBS). Unlike medications that primarily aim to relieve symptoms like pain or diarrhea, this diet targets the root cause by altering the food intake to prevent symptoms from occurring in the first place. Researchers are excited about this approach because it offers a non-pharmacological option that empowers patients to manage their condition through dietary changes, potentially reducing reliance on medications and improving quality of life.
What evidence suggests that the FODMAP diet might be an effective treatment for IBS?
Studies have shown that a low FODMAP diet, which participants in this trial will follow, can be very effective for people with irritable bowel syndrome (IBS). Up to 86% of IBS patients report less abdominal pain and bloating when following this diet. Research indicates that the low FODMAP diet promotes healthier eating and significantly reduces IBS symptoms over time. One study found this diet highly effective in reducing symptoms like abdominal pain and bloating. Overall, many patients experience clear relief from IBS symptoms with a low FODMAP diet.678910
Who Is on the Research Team?
Judy Nee, MD
Principal Investigator
Beth Israel Deaconess Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with Irritable Bowel Syndrome (IBS), specifically those who often have diarrhea. Participants must have normal blood and stool test results, no C diff infections or parasites, and a certain score on an IBS symptom severity scale.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow a low FODMAP diet to assess its effects on colonic permeability, microbiome, and immune cells
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- FODMAP diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor
University of Michigan
Collaborator